Publication

Evolv Express® Named “Best in Sports Technology” 2024 by Sports Business Journal

Retrieved on: 
Thursday, March 7, 2024

Later, at the end of an awards ceremony attended by hundreds of executives, technologists, journalists, and other sports industry leaders, Express was further honored as the “Best in Sports Technology” for 2024.

Key Points: 
  • Later, at the end of an awards ceremony attended by hundreds of executives, technologists, journalists, and other sports industry leaders, Express was further honored as the “Best in Sports Technology” for 2024.
  • The second honor put Express first among a total of 34 nominees in six categories, which in turn, were drawn from 271 submissions.
  • To date, Evolv Express is deployed at almost 50 major pro and collegiate sports venues in the United States and England.
  • Sports Business Journal (SBJ) is the sports industry’s business media source of record.

 Zebra Technologies Named a Leader in 2024 Gartner® Magic Quadrant™ for Indoor Location Services

Retrieved on: 
Thursday, March 7, 2024

Zebra Technologies Corporation (NASDAQ: ZBRA), a leading digital solution provider enabling businesses to intelligently connect data, assets, and people, today announced it has been named a Leader by Gartner, Inc. in its Magic Quadrant for Indoor Location Services.

Key Points: 
  • Zebra Technologies Corporation (NASDAQ: ZBRA), a leading digital solution provider enabling businesses to intelligently connect data, assets, and people, today announced it has been named a Leader by Gartner, Inc. in its Magic Quadrant for Indoor Location Services.
  • “We believe being recognized as a Leader by Gartner is a distinct honor,” said Brent Brown, General Manager, Advanced Location Technologies, Zebra Technologies.
  • For the fifth consecutive year, Zebra Technologies is named as a Leader in the Gartner Magic Quadrant for Indoor Location Services.
  • Gartner, Magic Quadrant for Indoor Location Services, Tim Zimmerman, Annette Zimmermann, 28 February 2024
    The report was published as Magic Quadrant for Indoor Location Services, Global for the year 2020-21.

Natera Announces Commercial Coverage for Prospera™ Kidney and Prospera Heart™ from a Top BCBS Plan

Retrieved on: 
Thursday, March 7, 2024

The coverage policy includes serial testing with Prospera to assess graft status and identify the risk of rejection following a kidney or heart transplant.

Key Points: 
  • The coverage policy includes serial testing with Prospera to assess graft status and identify the risk of rejection following a kidney or heart transplant.
  • “Improving long-term outcomes for this population starts with more accurate and non-invasive tools to identify potential graft issues earlier.”
    Natera and its academic partners have published significant peer-reviewed evidence supporting the clinical utility of Prospera.
  • In addition, Natera has completed enrollment in the PEDAL and MOTR trials.
  • These are both multi-site, prospective studies designed to provide novel evidence supporting the clinical utility of Prospera, with expected publication in 2024.

TriSalus Life Sciences Receives Approval from the World Health Organization and the American Medical Association’s Adopted Name Council for “Nelitolimod” as the Nonproprietary Drug Name for SD-101

Retrieved on: 
Thursday, March 7, 2024

“The WHO INN and USAN approval of nelitolimod is an important milestone in the continued progress we are making with our nelitolimod program,” said Mary Szela, Chief Executive Officer and President of TriSalus.

Key Points: 
  • “The WHO INN and USAN approval of nelitolimod is an important milestone in the continued progress we are making with our nelitolimod program,” said Mary Szela, Chief Executive Officer and President of TriSalus.
  • This approach has the potential to enable more durable responses by patients to other immunotherapeutics, thereby facilitating better patient outcomes.
  • Information on nelitolimod will be posted on the USAN website ( www.ama-assn.org/go/usan ) and will be published in the Chemical Abstracts Service and in the U.S. Pharmacopeia.
  • Going forward, TriSalus will use the name in publications and public statements, at conferences and other forums, and in corporate-related materials.

CLARA Analytics Achieves Record Revenue Growth, Accelerates Innovation

Retrieved on: 
Wednesday, March 6, 2024

The platform includes CLARA Triage , CLARA Treatment , CLARA Litigation , CLARA Optics and CLARA MSP Compliance modules, which enable claims professionals to choose specific capabilities to tackle their rising insurance claims challenges.

Key Points: 
  • The platform includes CLARA Triage , CLARA Treatment , CLARA Litigation , CLARA Optics and CLARA MSP Compliance modules, which enable claims professionals to choose specific capabilities to tackle their rising insurance claims challenges.
  • “Investors, industry leaders, and analysts are responding extremely positively to CLARA’s rapid growth and customer success,” said CLARA Analytics CEO Heather H. Wilson .
  • Last month, CLARA announced yet another infusion of capital from Nationwide Ventures , which invests in companies that are shaping the future of insurance and financial services.
  • CLARA’s growth is fueled by its track record of delivering strong ROI for its customers, along with its reputation for industry-leading innovation and customer service.

Revolutionary Elephant iPSC Milestone Reached in Colossal’s Woolly Mammoth Project

Retrieved on: 
Wednesday, March 6, 2024

Colossal Biosciences (“Colossal”), the world’s first de-extinction company, announces today that their Woolly Mammoth team has achieved a global-first iPSC (induced pluripotent stem cells) breakthrough.

Key Points: 
  • Colossal Biosciences (“Colossal”), the world’s first de-extinction company, announces today that their Woolly Mammoth team has achieved a global-first iPSC (induced pluripotent stem cells) breakthrough.
  • This milestone advancement was one of the primary early goals of the mammoth project, and supports the feasibility of future multiplex ex utero mammoth gestation.
  • Invaluable for Colossal’s Woolly Mammoths, these cells can be multiplex-edited and differentiated to study cold adaptation traits like woolly hair growth and fat storage in cellular and organoid models.
  • “In the past, a multitude of attempts to generate elephant iPSCs have not been fruitful.

Digilant Announces Relationship with Microsoft, Expanding Digital Media Access for Advertisers

Retrieved on: 
Tuesday, March 5, 2024

Today, Digilant, the digital media partner of choice for mid-market advertisers, announced its collaboration with Microsoft, adding its DSP, Invest, and its deal curation platform, Curate, to its tech stack.

Key Points: 
  • Today, Digilant, the digital media partner of choice for mid-market advertisers, announced its collaboration with Microsoft, adding its DSP, Invest, and its deal curation platform, Curate, to its tech stack.
  • This approach offers Digilant’s clients greater access to premium advertising inventory and advanced audience targeting solutions.
  • By working with Microsoft, Digilant reiterates its commitment to enabling advertisers with access to technology and media in a cookieless world," said Raquel Rosenthal, CEO at Digilant.
  • Moreover, Microsoft’s exclusive access to connected TV inventory on Netflix will enable Digilant to reach audiences on one of the world's most popular entertainment services.

ARC Fertility Teams Up with Leapfrog for High-Value Family-Forming Benefits Webinar, Invites Self Insurance Stakeholders to Attend

Retrieved on: 
Tuesday, March 5, 2024

In collaboration with Leapfrog , this webinar is a testament to Leapfrog's dedication to fostering industry dialogue through its Partner Advisory Committee (PAC) where ARC Fertility is a proud member.

Key Points: 
  • In collaboration with Leapfrog , this webinar is a testament to Leapfrog's dedication to fostering industry dialogue through its Partner Advisory Committee (PAC) where ARC Fertility is a proud member.
  • David Adamson, MD, FRCSC, FACOG, FACS, Founder and CEO, ARC Fertility, and Eliza Chin, MD, MPH, Executive Director, American Medical Women's Association (AMWA), will lead the discussion.
  • ARC Fertility is set to guide CEOs, CFOs and corporate human resources (CHRs) through the intricate landscape of family-forming benefits.
  • Drawing from our experience, we will explore the challenges employers face and the benefits of a flexible and affordable family-forming benefits solution.

Bicycle Therapeutics to Present at the AACR Annual Meeting 2024

Retrieved on: 
Tuesday, March 5, 2024

Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced the acceptance of three abstracts for poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2024, taking place in San Diego on April 5-10.

Key Points: 
  • Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced the acceptance of three abstracts for poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2024, taking place in San Diego on April 5-10.
  • Title: Modulation of the natural killer cell immune response to tumor with a synthetic tumor-immune cell agonist, NK-TICA™
    Title: Tumor-targeted activation of CD137 using Bicycles: New insights into mechanism of action and discovery of BT7455, a clinical candidate for the treatment of EphA2-expressing cancers
    The posters will be made available in the Publications section of bicycletherapeutics.com following the presentations.

Grants Works Consulting Hosts Federal Grant Funding and Management Summit

Retrieved on: 
Wednesday, March 6, 2024

Grants Works Consulting will host its Federal Grant Funding and Management Summit at Commerce Club ATL in Atlanta, Georgia on Thursday, March 28, 2024.

Key Points: 
  • Grants Works Consulting will host its Federal Grant Funding and Management Summit at Commerce Club ATL in Atlanta, Georgia on Thursday, March 28, 2024.
  • Grants Works wants to be part of the solution and we’re doing it by hosting the summit,” said Grants Works’ CEO, Patrice Davis.
  • To address this information gap, the team at Grants Works selected speakers and crafted sessions so attendees leave the summit informed about what it takes to obtain and manage federal grant funding.
  • Grants Works Consulting is a federal grant consulting firm based in Atlanta, GA. We provide a range of pre- and post-award services to support clients as they identify, obtain, manage, and comply with federal and other government grants.